Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis
- 1 August 2000
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 356 (9228) , 449-454
- https://doi.org/10.1016/s0140-6736(00)02552-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: The ASSENT-1 trialAmerican Heart Journal, 1999
- An angiographic assessment of alteplase: Double-bolus and front-loaded infusion regimens in myocardial infarctionAmerican Heart Journal, 1998
- Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarctionThe American Journal of Cardiology, 1993
- Effectiveness of double bolus alteplase in the treatment of acute myocardial infarctionThe American Journal of Cardiology, 1991
- Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarctionThe American Journal of Cardiology, 1991
- Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: Results of the anistreplase reocclusion multicenter study (ARMS)The American Journal of Cardiology, 1991
- Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1989
- Anisoylated Plasminogen Streptokinase Activator Complex versus Streptokinase in Acute Myocardial InfarctionDrugs, 1987
- Intravenous urokinase in acute myocardial infarctionThe American Journal of Cardiology, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985